Periodic Reporting for period 1 - TALVIN (Inhibiting mechanotransduction for the treatment of pancreatic cancer)

Pancreatic cancer is the fourth cause of cancer-related deaths across the world. Once it is diagnosed, it also has the lowest survival rate of all major cancers, as only 2-10% of diagnosed people survive after five years. Chemotherapy and radiation therapies are well...